These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 29939462)

  • 1. Thinking Outside the Box-Novel Antibacterials To Tackle the Resistance Crisis.
    Lakemeyer M; Zhao W; Mandl FA; Hammann P; Sieber SA
    Angew Chem Int Ed Engl; 2018 Oct; 57(44):14440-14475. PubMed ID: 29939462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Innovative Medicines Initiative's New Drugs for Bad Bugs programme: European public-private partnerships for the development of new strategies to tackle antibiotic resistance.
    Kostyanev T; Bonten MJ; O'Brien S; Steel H; Ross S; François B; Tacconelli E; Winterhalter M; Stavenger RA; Karlén A; Harbarth S; Hackett J; Jafri HS; Vuong C; MacGowan A; Witschi A; Angyalosi G; Elborn JS; deWinter R; Goossens H
    J Antimicrob Chemother; 2016 Feb; 71(2):290-5. PubMed ID: 26568581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systems-Level Chemical Biology to Accelerate Antibiotic Drug Discovery.
    Farha MA; French S; Brown ED
    Acc Chem Res; 2021 Apr; 54(8):1909-1920. PubMed ID: 33787225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The antibiotic resistome: challenge and opportunity for therapeutic intervention.
    Martínez JL
    Future Med Chem; 2012 Mar; 4(3):347-59. PubMed ID: 22393941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel approaches are needed to develop tomorrow's antibacterial therapies.
    Spellberg B; Bartlett J; Wunderink R; Gilbert DN
    Am J Respir Crit Care Med; 2015 Jan; 191(2):135-40. PubMed ID: 25590154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different drugs for bad bugs: antivirulence strategies in the age of antibiotic resistance.
    Dickey SW; Cheung GYC; Otto M
    Nat Rev Drug Discov; 2017 Jul; 16(7):457-471. PubMed ID: 28337021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Virulence-targeted Antibacterials: Concept, Promise, and Susceptibility to Resistance Mechanisms.
    Ruer S; Pinotsis N; Steadman D; Waksman G; Remaut H
    Chem Biol Drug Des; 2015 Oct; 86(4):379-99. PubMed ID: 25589217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America.
    Boucher HW; Talbot GH; Bradley JS; Edwards JE; Gilbert D; Rice LB; Scheld M; Spellberg B; Bartlett J
    Clin Infect Dis; 2009 Jan; 48(1):1-12. PubMed ID: 19035777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biosensor applications in the field of antibiotic research--a review of recent developments.
    Reder-Christ K; Bendas G
    Sensors (Basel); 2011; 11(10):9450-66. PubMed ID: 22163705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecules that Inhibit Bacterial Resistance Enzymes.
    Liu Y; Li R; Xiao X; Wang Z
    Molecules; 2018 Dec; 24(1):. PubMed ID: 30583527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fighting antibiotic resistance-strategies and (pre)clinical developments to find new antibacterials.
    Walesch S; Birkelbach J; Jézéquel G; Haeckl FPJ; Hegemann JD; Hesterkamp T; Hirsch AKH; Hammann P; Müller R
    EMBO Rep; 2023 Jan; 24(1):e56033. PubMed ID: 36533629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural products as a source of drug leads to overcome drug resistance.
    Silver LL
    Future Microbiol; 2015; 10(11):1711-8. PubMed ID: 26517443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Common Platform for Antibiotic Dereplication and Adjuvant Discovery.
    Cox G; Sieron A; King AM; De Pascale G; Pawlowski AC; Koteva K; Wright GD
    Cell Chem Biol; 2017 Jan; 24(1):98-109. PubMed ID: 28017602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renaissance in Antibiotic Discovery: Some Novel Approaches for Finding Drugs to Treat Bad Bugs.
    Gadakh B; Van Aerschot A
    Curr Med Chem; 2015; 22(18):2140-58. PubMed ID: 25787965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The re-emerging role of microbial natural products in antibiotic discovery.
    Genilloud O
    Antonie Van Leeuwenhoek; 2014 Jul; 106(1):173-88. PubMed ID: 24923558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rational approaches towards inorganic and organometallic antibacterials.
    Hess J
    Biol Chem; 2022 Mar; 403(4):363-375. PubMed ID: 34253000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antivirulence drugs to target bacterial secretion systems.
    Baron C
    Curr Opin Microbiol; 2010 Feb; 13(1):100-5. PubMed ID: 20079679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel Antibacterials: Alternatives to Traditional Antibiotics.
    Betts JW; Hornsey M; La Ragione RM
    Adv Microb Physiol; 2018; 73():123-169. PubMed ID: 30262108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacterial histidine kinases as novel antibacterial drug targets.
    Bem AE; Velikova N; Pellicer MT; Baarlen Pv; Marina A; Wells JM
    ACS Chem Biol; 2015 Jan; 10(1):213-24. PubMed ID: 25436989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using bacterial genomes and essential genes for the development of new antibiotics.
    Fields FR; Lee SW; McConnell MJ
    Biochem Pharmacol; 2017 Jun; 134():74-86. PubMed ID: 27940263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.